ConductScience.org, home

Paper36978351

Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis.

Li D and 1 other. Antibiotics (Basel), 2023. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis. Papers, record 36978351. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36978351

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Current and Emerging Inhaled Antibiotics for Chronic Pulmonary Pseudomonas aeruginosa and Staphylococcus aureus Infections in Cystic Fibrosis.
PubMed
Journal
Antibiotics (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
4.83
iCite
Revised in PubMed
2023-03-31
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li DDanni
2Schneider-Futschik EKElena Khttps://orcid.org/0000-0001-6044-4824

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References94

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119805554In vitro pharmacodynamics of levofloxacin and other aerosolized antibiotics under multiple conditions relevant to chronic pulmonary infection in cystic fibrosis.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/19805554PubMed
225753888The use of vancomycin with its therapeutic and adverse effects: a review.Eur Rev Med Pharmacol Sci2015https://conductscience.org/library/papers/25753888PubMed
330073802Biology and management of methicillin resistant Staphylococcus aureus in cystic fibrosis.Pediatr Pulmonol2018https://conductscience.org/library/papers/30073802PubMed
48146414Nebulized colistin causes chest tightness in adults with cystic fibrosis.Respir Med1994https://conductscience.org/library/papers/8146414PubMed
525278817Colistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapy.Core Evid2014https://conductscience.org/library/papers/25278817PubMed
621075062Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: The EAGER trial.J Cyst Fibros2011https://conductscience.org/library/papers/21075062PubMed
734384254Management of chronic Pseudomonas aeruginosa infection with inhaled levofloxacin in people with cystic fibrosis.Future Microbiol2021https://conductscience.org/library/papers/34384254PubMed
816687478Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/16687478PubMed
918658109Inhaled aztreonam lysine for chronic airway Pseudomonas aeruginosa in cystic fibrosis.Am J Respir Crit Care Med2008https://conductscience.org/library/papers/18658109PubMed
1032807645Long-term safety study of colistimethate sodium (Colobreathe®): Findings from the UK Cystic Fibrosis Registry.J Cyst Fibros2021https://conductscience.org/library/papers/32807645PubMed
1126573178Management of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin.Future Microbiol2015https://conductscience.org/library/papers/26573178PubMed
1234144923Long-term amikacin liposome inhalation suspension in cystic fibrosis patients with chronic P. aeruginosa infection.J Cyst Fibros2021https://conductscience.org/library/papers/34144923PubMed
1320735333Resistance to tobramycin and colistin in isolates of Pseudomonas aeruginosa from chronically colonized patients with cystic fibrosis under antimicrobial treatment.Scand J Infect Dis2010https://conductscience.org/library/papers/20735333PubMed
1410926333A ten year review of colomycin.Respir Med2000https://conductscience.org/library/papers/10926333PubMed
1515705991Bronchial constriction and inhaled colistin in cystic fibrosis.Chest2005https://conductscience.org/library/papers/15705991PubMed
1631447669Antimicrobial Treatment of Staphylococcus aureus in Patients With Cystic Fibrosis.Front Pharmacol2019https://conductscience.org/library/papers/31447669PubMed
1722354300In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22354300PubMed
183301785Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.J Antimicrob Chemother1987https://conductscience.org/library/papers/3301785PubMed
1932566909Metabolomic Description of Ivacaftor Elevating Polymyxin B Mediated Antibacterial Activity in Cystic Fibrosis Pseudomonas aeruginosa.ACS Pharmacol Transl Sci2020https://conductscience.org/library/papers/32566909PubMed
202170321Rapid emergence of resistance in Pseudomonas aeruginosa in cystic fibrosis patients due to in-vivo selection of stable partially derepressed beta-lactamase producing strains.J Antimicrob Chemother1990https://conductscience.org/library/papers/2170321PubMed

See all 94 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
42747544Inhalable Dry Powders of Antimicrobial Agents in Respiratory Diseases.Lung2026https://conductscience.org/library/papers/42747544PubMed
42041359Detection to Disruption: A Comprehensive Review of Bacterial Biofilms and Therapeutic Advances.Antibiotics (Basel)2026https://conductscience.org/library/papers/42041359PubMed
41898631Distinct CFTR Mutation Spectrum and Atypical Clinical Presentations in Chinese Patients with Cystic Fibrosis.Int J Mol Sci2026https://conductscience.org/library/papers/41898631PubMed
41583061Liposomal antimicrobials in the fight against bacterial and fungal pathogens: Clinical successes and development challenges.Int J Pharm X2026https://conductscience.org/library/papers/41583061PubMed
41416830Inhaled liposomal ciprofloxacin protects against lethal tularemia in the common marmoset.Antimicrob Agents Chemother2026https://conductscience.org/library/papers/41416830PubMed
41364184Sub-inhibitory tobramycin concentration suppresses ToxA and LipA in single- and dual-species biofilms.Braz J Microbiol2025https://conductscience.org/library/papers/41364184PubMed
41328407Phenotypic and Molecular Analysis of Fosfomycin Resistance Among P. aeruginosa Isolates from Cystic Fibrosis Patients.Infect Drug Resist2025https://conductscience.org/library/papers/41328407PubMed
41083887Bacterial cell envelope-targeting antibiotics.Nat Rev Microbiol2026https://conductscience.org/library/papers/41083887PubMed
40871096Latest Advances in Inhalable Dry Powder Bacteriophage Therapy for Pulmonary Infections.Pharmaceutics2025https://conductscience.org/library/papers/40871096PubMed
40284567Diversification of Pseudomonas aeruginosa After Inhaled Tobramycin Therapy of Cystic Fibrosis Patients: Genotypic and Phenotypic Characteristics of Paired Pre- and Post-Treatment Isolates.Microorganisms2025https://conductscience.org/library/papers/40284567PubMed
40223951
Comparative efficacy and safety of inhaled antibiotics in managing chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis and bronchiectasis: a systematic review and network meta-analysis.
J Thorac Dis2025https://conductscience.org/library/papers/40223951PubMed
40001425Eisenia bicyclis-Mediated Gold Nanoparticles Exhibit Antibiofilm and Antivirulence Activities Against Pseudomonas aeruginosa and Staphylococcus aureus.Antibiotics (Basel)2025https://conductscience.org/library/papers/40001425PubMed
39779734DJK-5, an anti-biofilm peptide, increases Staphylococcus aureus sensitivity to colistin killing in co-biofilms with Pseudomonas aeruginosa.NPJ Biofilms Microbiomes2025https://conductscience.org/library/papers/39779734PubMed
39771486Development and Characterization of Spray-Dried Combined Levofloxacin-Ambroxol Dry Powder Inhaler Formulation.Pharmaceutics2024https://conductscience.org/library/papers/39771486PubMed
39334985Murepavadin Enhances the Killing Efficacy of Ciprofloxacin against Pseudomonas aeruginosa by Inhibiting Drug Efflux.Antibiotics (Basel)2024https://conductscience.org/library/papers/39334985PubMed
38816673Structural Insights into the Lipopolysaccharide Transport (Lpt) System as a Novel Antibiotic Target.J Microbiol2024https://conductscience.org/library/papers/38816673PubMed
38702073Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapy.BMJ Open Respir Res2024https://conductscience.org/library/papers/38702073PubMed
38172634A novel antibiotic class targeting the lipopolysaccharide transporter.Nature2024https://conductscience.org/library/papers/38172634PubMed
38019899Structure-Interaction Relationship of Polymyxins with Lung Surfactant.J Med Chem2023https://conductscience.org/library/papers/38019899PubMed
37764311Development of Quinazolinone Derivatives as Modulators of Virulence Factors of Pseudomonas aeruginosa Cystic Fibrosis Strains.Molecules2023https://conductscience.org/library/papers/37764311PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CFTR1080PubTator's text mininghttps://conductscience.org/library/genes/1080NCBI Gene
TOP2A7153PubTator's text mininghttps://conductscience.org/library/genes/7153NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36978351

GET https://conductscience.org/api/papers/v1/36978351/references?page=2